Acadia Healthcare (NASDAQ:ACHC) Hits New 12-Month Low – Time to Sell?

Acadia Healthcare Company, Inc. (NASDAQ:ACHC)’s share price reached a new 52-week low on Thursday . The company traded as low as $39.60 and last traded at $39.90, with a volume of 51596 shares traded. The stock had previously closed at $39.83.

Analysts Set New Price Targets

A number of research analysts have weighed in on ACHC shares. StockNews.com raised shares of Acadia Healthcare from a “sell” rating to a “hold” rating in a research report on Thursday. Royal Bank of Canada reaffirmed an “outperform” rating and set a $94.00 price objective on shares of Acadia Healthcare in a research report on Friday, September 20th. Barclays cut their price objective on shares of Acadia Healthcare from $83.00 to $76.00 and set an “overweight” rating for the company in a research report on Monday, September 30th. Deutsche Bank Aktiengesellschaft upped their target price on shares of Acadia Healthcare from $70.00 to $75.00 and gave the company a “hold” rating in a research note on Friday, August 2nd. Finally, Cantor Fitzgerald reissued a “neutral” rating and issued a $90.00 target price on shares of Acadia Healthcare in a research note on Tuesday, October 1st. Five investment analysts have rated the stock with a hold rating and six have assigned a buy rating to the stock. According to data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $86.67.

Acadia Healthcare Price Performance

The company’s fifty day moving average is $58.05 and its two-hundred day moving average is $65.66. The company has a quick ratio of 1.07, a current ratio of 1.07 and a debt-to-equity ratio of 0.60. The firm has a market capitalization of $3.51 billion, a price-to-earnings ratio of 12.40, a price-to-earnings-growth ratio of 1.76 and a beta of 1.33.

Acadia Healthcare (NASDAQ:ACHC) last issued its quarterly earnings data on Wednesday, October 30th. The company reported $0.91 EPS for the quarter, topping analysts’ consensus estimates of $0.90 by $0.01. The business had revenue of $815.60 million for the quarter, compared to analyst estimates of $819.42 million. Acadia Healthcare had a net margin of 8.99% and a return on equity of 11.12%. The firm’s quarterly revenue was up 8.7% on a year-over-year basis. During the same period last year, the business posted $0.91 earnings per share. Equities research analysts anticipate that Acadia Healthcare Company, Inc. will post 3.38 earnings per share for the current fiscal year.

Institutional Trading of Acadia Healthcare

Hedge funds and other institutional investors have recently bought and sold shares of the business. GAMMA Investing LLC raised its position in shares of Acadia Healthcare by 57.1% in the 3rd quarter. GAMMA Investing LLC now owns 663 shares of the company’s stock valued at $42,000 after buying an additional 241 shares in the last quarter. Blue Trust Inc. grew its holdings in shares of Acadia Healthcare by 86.1% during the 2nd quarter. Blue Trust Inc. now owns 536 shares of the company’s stock valued at $36,000 after purchasing an additional 248 shares during the last quarter. Commonwealth Equity Services LLC grew its holdings in shares of Acadia Healthcare by 3.5% during the 2nd quarter. Commonwealth Equity Services LLC now owns 7,595 shares of the company’s stock valued at $513,000 after purchasing an additional 257 shares during the last quarter. Atria Investments Inc grew its holdings in shares of Acadia Healthcare by 4.7% during the 3rd quarter. Atria Investments Inc now owns 6,844 shares of the company’s stock valued at $434,000 after purchasing an additional 308 shares during the last quarter. Finally, KBC Group NV grew its holdings in shares of Acadia Healthcare by 14.4% during the 3rd quarter. KBC Group NV now owns 2,688 shares of the company’s stock valued at $170,000 after purchasing an additional 338 shares during the last quarter.

Acadia Healthcare Company Profile

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.